Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

Completed · Phase 1

Conditions studied: HIV-1-infection

In brief

This is a First in Human (FIH) study of EBT-101 administered IV to aviremic HIV-1 infected adults on stable antiretroviral therapy (ART).

Key facts

Study ID

NCT05144386

Run by

Excision BioTherapeutics

People needed

6

Starts

2022-01-24

Expected to finish

2024-11-14

Last updated by the study team

2024-12-02

Who can join

Age: 18 and older, up to 70. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Quest Clinical Research — San Francisco, California, United States
• Washington University — St Louis, Missouri, United States
• Cooper Health — Camden, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.